Redwood City, United States
Betteromics, founded in 2019, is an innovative player within the Analytics and IT sectors, headquartered in the United States. The company operates as a GenAI-powered, secure, collaborative, cloud-based DevOps-as-a-Service (DaaS) platform aimed at expediting innovation across life science companies. Through the integration of cutting-edge science and generative AI, Betteromics offers tools that streamline processes and manage vast quantities of multimodal data throughout the drug lifecycle.
The platform shines by providing real-time insights and advanced signal detection that aid in data-driven decision-making, aligning seamlessly with the personalisation needs of modern medicine development. The company’s slogan, "AI Platform for Life Sciences that Scales", encapsulates its mission to amplify the power of technology in science.
In its recent Series A funding round, Betteromics secured a $20.00M investment from notable investors such as Sofinnova Partners, Triatomic Capital, and SHAKTI Ventures, underscoring significant vote of confidence in its potential to innovate further in the life sciences sector.
